A clear introduction to two peptides associated with growth-hormone signaling exploring how they differ, why they are often discussed together and what current research tells us.
CJC-1295 and Ipamorelin are synthetic peptides studied for their interaction with growth-hormone pathways. CJC-1295 acts as a long-acting analogue of growth hormone-releasing hormone, while Ipamorelin acts through a separate growth-hormone secretagogue pathway.
Human studies have shown that CJC-1295 can increase growth hormone and IGF-1 levels for an extended period following administration.
Ipamorelin has also been studied in human volunteers and has demonstrated an ability to stimulate growth-hormone release through a different signaling pathway.
Because the two peptides interact with different parts of growth-hormone signaling, they are sometimes discussed together in wellness settings.
Sleep, recovery, body composition and energy concerns can have many possible causes. A complete health review should come before focusing on a specific peptide.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone studied for its effects on growth hormone and IGF-1.
Ipamorelin is a synthetic peptide studied for its ability to stimulate growth-hormone release through a separate signaling pathway.
They influence different parts of growth-hormone signaling, which is why they are sometimes paired in wellness conversations.
Yes. Katie can review your concerns and determine whether relevant testing or another wellness pathway may be useful.
